Trials that use: Risk ratio / relative risk
New to this method? Read the tutorial →
6,204 results
- Pilot Study PBSCT With TCRab Depletion For Hemoglobinopathies: Complete Statistical AnalysisIndependent statistical analysis of Pilot Study PBSCT With TCRab Depletion For Hemoglobinopathies: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT04523376).
- Pilot Study to Evaluate Reparixin With Weekly Paclitaxel in Patients With HER 2 Negative Metastatic Breast Cancer (MBC): Complete Statistical AnalysisIndependent statistical analysis of Pilot Study to Evaluate Reparixin With Weekly Paclitaxel in Patients With HER 2 Negative Metastatic Breast Cancer (MBC): primary endpoint results, effect estimate with confidence interval, sample-size planning…
- Pilot Study: Preoperative Nicotine Lozenges: Complete Statistical AnalysisIndependent statistical analysis of Pilot Study: Preoperative Nicotine Lozenges: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00586482).
- Pilot Testing of a Behavioral Intervention for Chronic Pain in Individuals With HIV: Complete Statistical AnalysisIndependent statistical analysis of Pilot Testing of a Behavioral Intervention for Chronic Pain in Individuals With HIV: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…
- Pilot Trial of “Chemo-Switch” Regimen to Treat Advanced Melanoma: Complete Statistical AnalysisIndependent statistical analysis of Pilot Trial of "Chemo-Switch" Regimen to Treat Advanced Melanoma: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00673361).
- Pilot, Neoadjuvant Gemcitabine and Abraxane Chemotherapy Followed by Surgery, Adenocarcinoma of the Pancreas: Complete Statistical AnalysisIndependent statistical analysis of Pilot, Neoadjuvant Gemcitabine and Abraxane Chemotherapy Followed by Surgery, Adenocarcinoma of the Pancreas: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…
- Piloting ‘mPal,’ a Multilevel Strategy for Palliative Care Implementation: Complete Statistical AnalysisIndependent statistical analysis of Piloting 'mPal,' a Multilevel Strategy for Palliative Care Implementation: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT05270395).
- PilotNR-LVADIndependent statistical analysis of Nicotinamide Riboside in LVAD Recipients: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03727646).
- Pinometostat With Standard Chemotherapy in Treating Patients With Newly Diagnosed Acute Myeloid Leukemia and MLL Gene Rearrangement: Complete Statistical AnalysisIndependent statistical analysis of Pinometostat With Standard Chemotherapy in Treating Patients With Newly Diagnosed Acute Myeloid Leukemia and MLL Gene Rearrangement: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration,…
- PinPointe FootLaser for the Treatment of Onychomycosis: Complete Statistical AnalysisIndependent statistical analysis of PinPointe FootLaser for the Treatment of Onychomycosis: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00935649).
- Pioglitazone Special Drug Use Surveillance “Metabolic Syndrome in Patients With Type 2 Diabetes Mellitus”: Complete Statistical AnalysisIndependent statistical analysis of Pioglitazone Special Drug Use Surveillance "Metabolic Syndrome in Patients With Type 2 Diabetes Mellitus": primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based…
- Pioglitazone/Glimepiride (Sonias) Combination Tablets Special Drug Use Surveillance Survey in Patients With Type 2 Diabetes Mellitus Who Respond Poorly to Pioglitazone: Complete Statistical AnalysisIndependent statistical analysis of Pioglitazone/Glimepiride (Sonias) Combination Tablets Special Drug Use Surveillance Survey in Patients With Type 2 Diabetes Mellitus Who Respond Poorly to Pioglitazone: primary endpoint results, effect estimate with confidence…
- PIONEER AF-PCIIndependent statistical analysis of A Study Exploring Two Strategies of Rivaroxaban (JNJ39039039; BAY-59-7939) and One of Oral Vitamin K Antagonist in Patients With Atrial Fibrillation Who Undergo Percutaneous Coronary Intervention: primary endpoint…
- Pivotal Study (Pharmacokinetics, Efficacy, Safety) of BAX 326 (rFIX) in Hemophilia B Patients: Complete Statistical AnalysisIndependent statistical analysis of Pivotal Study (Pharmacokinetics, Efficacy, Safety) of BAX 326 (rFIX) in Hemophilia B Patients: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…
- Pivotal Study of Iodine I 131 Tositumomab for Chemotherapy-refractory Low-grade or Transformed Low-grade B-cell Non-Hodgkin’s Lymphoma: Complete Statistical AnalysisIndependent statistical analysis of Pivotal Study of Iodine I 131 Tositumomab for Chemotherapy-refractory Low-grade or Transformed Low-grade B-cell Non-Hodgkin's Lymphoma: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and…
- Pivotal, Multicenter, Observer-Blind, Randomized Study of Influenza A (H1N1)2009 Monovalent Subunit Vaccine With and Without Adjuvant in Children Ages 6 to <36 Months: Complete Statistical AnalysisIndependent statistical analysis of Pivotal, Multicenter, Observer-Blind, Randomized Study of Influenza A (H1N1)2009 Monovalent Subunit Vaccine With and Without Adjuvant in Children Ages 6 to
- PIX-RIndependent statistical analysis of Comparison of Pixantrone + Rituximab With Gemcitabine + Rituximab in Patients With Aggressive B-cell Non-Hodgkin Lymphoma or Follicular Grade 3 Lymphoma Who Have Relapsed After Therapy and Are…
- PK and ECG Determinations Following 8 Weeks of HyBryte Treatment for Cutaneous T-Cell Lymphoma: Complete Statistical AnalysisIndependent statistical analysis of PK and ECG Determinations Following 8 Weeks of HyBryte Treatment for Cutaneous T-Cell Lymphoma: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based…
- PK Profile and Preliminary Efficacy of TNP-2092 Capsules in Liver Cirrhosis Patients With Hyperammonemia: Complete Statistical AnalysisIndependent statistical analysis of PK Profile and Preliminary Efficacy of TNP-2092 Capsules in Liver Cirrhosis Patients With Hyperammonemia: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based…
- Placebo Controlled, Dose Response, Safety and Immunogenicity Study of Vesicular Stomatitis Virus (VSV) Ebola Vaccine in Healthy Adults (V920-004): Complete Statistical AnalysisIndependent statistical analysis of Placebo Controlled, Dose Response, Safety and Immunogenicity Study of Vesicular Stomatitis Virus (VSV) Ebola Vaccine in Healthy Adults (V920-004): primary endpoint results, effect estimate with confidence interval, sample-size…
- Placebo-Controlled Trial of Antibiotic Therapy in Adults With Suspect Lower Respiratory Tract Infection (LRTI) and a Procalcitonin Level: Complete Statistical AnalysisIndependent statistical analysis of Placebo-Controlled Trial of Antibiotic Therapy in Adults With Suspect Lower Respiratory Tract Infection (LRTI) and a Procalcitonin Level: primary endpoint results, effect estimate with confidence interval, sample-size planning…
- Placebo-Corrected Effects of Therapeutic Dose (100 mg) and Supratherapeutic Dose (300 mg) of ITF2357 (Givinostat) and Moxifloxacin on QT/QTC Interval: Complete Statistical AnalysisIndependent statistical analysis of Placebo-Corrected Effects of Therapeutic Dose (100 mg) and Supratherapeutic Dose (300 mg) of ITF2357 (Givinostat) and Moxifloxacin on QT/QTC Interval: primary endpoint results, effect estimate with confidence interval,…
- Plan and Pledge, HIV Self-testing in South Africa: Complete Statistical AnalysisIndependent statistical analysis of Plan and Pledge, HIV Self-testing in South Africa: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03898557).
- PLANETIndependent statistical analysis of Aflibercept in Polypoidal Choroidal Vasculopathy: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02120950).
- PLANET 1Independent statistical analysis of Prospective Evaluation of Proteinuria and Renal Function in Diabetic Patients With Progressive Renal Disease: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based…
- Planned Donor Lymphocyte Infusion (DLI) After Allogeneic Stem Cell Transplantation (SCT): Complete Statistical AnalysisIndependent statistical analysis of Planned Donor Lymphocyte Infusion (DLI) After Allogeneic Stem Cell Transplantation (SCT): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- Plasma Therapy of COVID-19 in Severely Ill Patients: Complete Statistical AnalysisIndependent statistical analysis of Plasma Therapy of COVID-19 in Severely Ill Patients: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT04359810).
- Plasmodium Vivax Efficacy Trial in Cruzeiro do Sul, Acre, Brazil: Complete Statistical AnalysisIndependent statistical analysis of Plasmodium Vivax Efficacy Trial in Cruzeiro do Sul, Acre, Brazil: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02043652).
- PLATINUM QCAIndependent statistical analysis of A Prospective, Multi-center Trial to Assess an Everolimus-Eluting Coronary Stent System (PROMUS Element™): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…
- Platinum-Based Chemotherapy Plus Ramucirumab in Patients With Advanced NSCLC Who Have Progressed on First Line Anti-PD-1 Immunotherapy: Complete Statistical AnalysisIndependent statistical analysis of Platinum-Based Chemotherapy Plus Ramucirumab in Patients With Advanced NSCLC Who Have Progressed on First Line Anti-PD-1 Immunotherapy: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration,…
- Plerixafor and Cemiplimab in Metastatic Pancreatic Cancer: Complete Statistical AnalysisIndependent statistical analysis of Plerixafor and Cemiplimab in Metastatic Pancreatic Cancer: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT04177810).
- Plerixafor and Filgrastim For Mobilization of Donor Peripheral Blood Stem Cells Before A Donor Peripheral Blood Stem Cell Transplant in Treating Patients With Hematologic Malignancies: Complete Statistical AnalysisIndependent statistical analysis of Plerixafor and Filgrastim For Mobilization of Donor Peripheral Blood Stem Cells Before A Donor Peripheral Blood Stem Cell Transplant in Treating Patients With Hematologic Malignancies: primary endpoint results,…
- PleuraSeal Post Market Study (Europe): Complete Statistical AnalysisIndependent statistical analysis of PleuraSeal Post Market Study (Europe): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00704171).
- Pleurectomy/Decortication With Intraoperative Intrathoracic/Intraperitoneal Heated Cisplatin With Sodium Thiosulfate: Complete Statistical AnalysisIndependent statistical analysis of Pleurectomy/Decortication With Intraoperative Intrathoracic/Intraperitoneal Heated Cisplatin With Sodium Thiosulfate: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00165503).
- PLHIVIndependent statistical analysis of Traditional Healers as Adherence Partners for Persons Living With HIV in Rural Mozambique: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…
- Ploidy and Stroma in Early Rectal Cancer: Complete Statistical AnalysisIndependent statistical analysis of Ploidy and Stroma in Early Rectal Cancer: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03039595).
- PLX038 (PEGylated SN38) and Rucaparib in Solid Tumors and Small Cell Cancers: Complete Statistical AnalysisIndependent statistical analysis of PLX038 (PEGylated SN38) and Rucaparib in Solid Tumors and Small Cell Cancers: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…
- PLX2853 as a Single Agent in Advanced Gynecological Malignancies and in Combination With Carboplatin in Platinum-Resistant Epithelial Ovarian Cancer: Complete Statistical AnalysisIndependent statistical analysis of PLX2853 as a Single Agent in Advanced Gynecological Malignancies and in Combination With Carboplatin in Platinum-Resistant Epithelial Ovarian Cancer: primary endpoint results, effect estimate with confidence interval, sample-size…
- PMCF Study on PEEK Suture Anchors for Shoulder Indications: Complete Statistical AnalysisIndependent statistical analysis of PMCF Study on PEEK Suture Anchors for Shoulder Indications: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03826667).
- PMS-001Independent statistical analysis of An Open-Label Study of Oral NNZ-2591 in Phelan-McDermid Syndrome (PMS-001): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT05025241).
- pNAATIndependent statistical analysis of Performance of Nucleic Acid Amplification Tests for the Detection of NG and CT: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…
- PNCAIndependent statistical analysis of Parent/Nurse Controlled Analgesia in the Neonatal Intensive Care Unit: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01823497).
- PNEU-AGEIndependent statistical analysis of Safety and Immunogenicity of V114 in Healthy Adults (V114-019/PNEU-AGE): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03950622).
- PNEU-WAY PEDIndependent statistical analysis of Safety and Immunogenicity of V114 in Children Infected With Human Immunodeficiency Virus (HIV) (V114-030/PNEU-WAY PED): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety,…
- Pneumococcal Vaccine Booster Study in Healthy Children 12-18 Mths Old Previously Primed With the Same Vaccines: Complete Statistical AnalysisIndependent statistical analysis of Pneumococcal Vaccine Booster Study in Healthy Children 12-18 Mths Old Previously Primed With the Same Vaccines: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and…
- PNPIndependent statistical analysis of BlueWind Medical Reprieve System for the Treatment of PNP: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02062398).
- PO-BADOIndependent statistical analysis of French Validation of an Interview Guide to Cancer Announcement : the Psycho Oncology Basic Documentation: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety,…
- PODOIndependent statistical analysis of A Study to Evaluate PF-06730512 in Adults With Focal Segmental Glomerulosclerosis (FSGS): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…
- POINTIndependent statistical analysis of Platelet-Oriented Inhibition in New TIA and Minor Ischemic Stroke (POINT) Trial: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- Polar Wand Carbon Dioxide Cryotherapy for Barrett’s Esophagus: Complete Statistical AnalysisIndependent statistical analysis of Polar Wand Carbon Dioxide Cryotherapy for Barrett's Esophagus: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01477177).